Boehringer’s lung drug Spiriva, approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2.4 billion euros, down 11.4% compared with last year, which the ...
"Millions of packages moved away from SurePost and the United States Postal Service and returned to UPS package cars this month, now being sorted and delivered by hardworking UPS Teamsters." ...
Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, dosage and administration, and formulary considerations of tiotropium are discussed. Conclusion ...
Tiotropium (Spiriva Respimat) and olodaterol (Striverdi Respimat) are bronchodilator drugs that come in a soft mist. Stiolto Respimat combines the drugs. More of the medication gets into your ...
As the EU patent expires on its flagship respiratory diseases product, Spiriva, Boehringer Ingelheim is looking to newer diabetes and respiratory drugs under the leadership of a new CEO.
Software to make running your open source project a little bit easier.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results